Perfusion treatment for malignant melanoma of the extremity.
D000671:Amputation, Surgical; D001855:Bone Marrow Diseases / Q000209:etiology; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects / Q000295:instrumentation; D005112:Extracorporeal Circulation; D005121:Extremities; D005205:Fascia; D005260:Female; D006509:Hepatitis B / Q000209:etiology; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000628:therapy*; D008558:Melphalan / Q000627:therapeutic use; D008722:Methods; D009336:Necrosis / Q000209:etiology; D009364:Neoplasm Recurrence, Local; D009443:Neuritis / Q000209:etiology; D011379:Prognosis; D013924:Thrombophlebitis / Q000209:etiology
D008558:Melphalan